Earnings
BIO
301.50
+0.65%
1.96
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
2.57B
2.57B
--
1.19B
1.38B
1.11B
814.00M
266.40M
--
--
29.50M
--
269.00M
-2.61B
--
1.60M
-2.34B
-498.30M
-1.84B
--
--
--
-1.84B
--
-1.84B
--
-1.84B
-1.84B
--
-1.84B
28.21M
-65.36
-65.36
--
-64.32
FY 2023
2.67B
2.67B
--
1.24B
1.43B
1.09B
824.22M
240.93M
--
--
27.90M
--
337.80M
-1.19B
--
4.84M
-850.10M
-212.78M
-637.32M
--
--
--
-637.32M
--
-637.32M
--
-637.32M
-637.32M
--
-637.32M
29.21M
-21.82
-21.82
--
-21.20
FY 2022
2.80B
2.80B
--
1.23B
1.57B
1.10B
824.83M
256.79M
--
--
14.70M
--
472.12M
-5.17B
--
-5.23M
-4.70B
-1.08B
-3.63B
--
--
--
-3.63B
--
-3.63B
--
-3.63B
-3.63B
--
-3.63B
29.79M
-121.79
-121.79
--
-121.47
FY 2021
2.92B
2.92B
--
1.26B
1.66B
1.16B
851.02M
247.34M
--
--
65.20M
--
499.54M
4.95B
--
675.00K
5.45B
1.19B
4.25B
--
--
--
4.25B
--
4.25B
--
4.25B
4.25B
--
4.25B
30.21M
140.83
140.83
--
142.52
FY 2020
2.55B
2.55B
--
1.11B
1.44B
1.01B
798.80M
217.76M
--
--
-7.10M
--
428.43M
4.49B
--
-1.81M
4.92B
1.10B
3.81B
--
--
--
3.81B
--
3.81B
--
3.81B
3.81B
--
3.81B
30.16M
126.47
126.47
--
126.28

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.